NewBlog
- By Equifund
Like this article? Share it with a friend:
This article is not an Equifund Crowd Funding Portal Inc communication. It is brought to you by Equifund Technologies, LLC.
All information contained in this communication should not be considered investment advice, but education and entertainment only.Investing in private or early stage offerings (such as Reg A, Reg S, Reg D, or Reg CF) involves a high degree of risk. Securities sold through these offerings are not publicly traded and, therefore, are illiquid. Additionally, investors will receive restricted stock that is subject to holding period requirements. Companies seeking capital through these offerings tend to be in earlier stages of development and have not yet been fully tested in the public marketplace. Investing in private or early stage offerings requires a tolerance for high risk, low liquidity, and a long-term commitment. Investors must be able to afford to lose their entire investment. Such investment products are not FDIC insured, may lose value, and have no bank guarantee.
More Gold as an Investment Articles:
Don't make another private market investment without reading this...
The 5 Mistakes
investors make that crush returns
Download this free report now:
Just enter your name & email to access this report for free.
By submitting your email address you will receive access to this report and a free subscription to Equifund’s private investment newsletter. You can unsubscribe at any time and read more about our privacy policy here.
More Articles:
Advertisement:
Kleiner Device Labs
- Patented devices that allow spine surgery to be less painful and less expensive with better outcomes
Investment Highlights:
- 1
Proprietary devices that could revolutionize spinal surgery and greatly improve success rates, reduce pain, and lower costs.
- 2
Over 20 patents have been issued to protect the company's technologies.
- 3
Just received FDA clearance for their next-generation KG2 spinal fusion technology.